Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

A patient developed a blister at the injection site after hepatitis C treatment.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Type I interferons play a key role in the development of various skin diseases.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Hydrogel with M2-derived exosomes improves wound healing by slowly releasing exosomes that help reduce inflammation and promote tissue repair.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Interferon therapy improves quality of life for chronic hepatitis B patients.